Who owns G1 Therapeutics?
- CUSIP Number: 3621lq109
Tip: Access positions for across all investors
Analyze quarterly positions in G1 Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of G1 Therapeutics stock
Who bought or sold G1 Therapeutics this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| BlackRock | 3.1M | $7.0M | 359% | Jun 2024 |
|
| Vanguard Group | 2.5M | $5.7M | 20% | Jun 2024 |
|
| State Street Corporation | 828k | $1.9M | 414% | Jun 2024 |
|
| Qube Research & Technologies | 801k | $1.8M | 147% | Jun 2024 |
|
| Morgan Stanley | 402k | $915k | 129% | Jun 2024 |
|
| Bridgeway Capital Management | 398k | $908k | 108% | Jun 2024 |
|
| Two Sigma Investments | 309k | $704k | -8% | Jun 2024 |
|
| Two Sigma Advisers | 212k | $483k | 15% | Jun 2024 |
|
| Goldman Sachs Group | 211k | $480k | -53% | Jun 2024 |
|
| PanAgora Asset Management | 177k | $404k | 100% | Jun 2024 |
|
| Virtu Financial | 74k | $170k | 100% | Jun 2024 |
|
| Nuveen Asset Management | 67k | $153k | 100% | Jun 2024 |
|
| Alpine Partners VI | 47k | $107k | 100% | Jun 2024 |
|
| Alliancebernstein | 22k | $51k | 100% | Jun 2024 |
|
| Cetera Investment Advisers | 11k | $25k | -5% | Jun 2024 |
|
| Tower Research Capital | 6.7k | $15k | 64% | Jun 2024 |
|
| Goss Wealth Management | 200.00 | $456.000000 | 0% | Jun 2024 |
|